OR WAIT null SECS
EVERSANA, a provider of next-generation commercial services to the global life sciences industry, has launched NAVLIN, described as a “comprehensive ecosystem of price and access solutions to help established and emerging pharmaceutical companies navigate global market access complexities.” The company reports that NAVLIN combines best-in-class data, software and insights into an integrated platform, backed by a team of innovative industry experts.
For ecosystem users, NAVLIN offers price and access data to set global pricing strategies and then apply those strategies to proprietary reference pricing. Additionally, the platform is said to provide in-depth market research insights into market access all the way through patient access.
Within the NAVLIN ecosystem, clients have unified access to
For more information, visit NAVLIN.COM.